Sign In
Get Clay Free →

Suggestions

    Guy Greiveldinger

    Guy Greiveldinger is the Head of Precision Medicine Business Development and Licensing (BD&L) at Novartis, specifically focusing on oncology. In this role, he is responsible for negotiating licensing agreements, overseeing development projects, and managing commercial strategies related to precision medicine initiatives within the company.13

    Greiveldinger has a notable background in the pharmaceutical industry, particularly in areas that intersect with precision medicine and oncology. His expertise encompasses both the scientific and business aspects of drug development, which is crucial for advancing therapeutic innovations in cancer treatment.4

    Before his current position, he has been associated with various roles that have contributed to his extensive experience in business development and strategic partnerships within the healthcare sector. His educational background and professional trajectory reflect a strong foundation in both the scientific and commercial dimensions of pharmaceuticals.23

    For further details about his career and contributions, you may refer to his LinkedIn profile or professional publications.14

    Highlights

    Former Members | Ellman Laboratory - Yale University

    Related Questions

    What are Guy Greiveldinger's main responsibilities at Novartis?
    How long has Guy Greiveldinger been with Novartis?
    What is Guy Greiveldinger's background before joining Novartis?
    What specific projects has Guy Greiveldinger led in Precision Medicine?
    How does Guy Greiveldinger contribute to Novartis's Oncology division?
    Guy Greiveldinger
    Add to my network

    Location

    Switzerland